Cardinal Health, Inc. (NYSE:CAH) retreated -0.81% and closed its last session at $70.99. The stock has the market capitalization of $22.72 Billion with the total outstanding shares of 320.06 Million. Cardinal Health, Inc.. has Analysts’ Mean Recommendation of 2.33 between the scale of 1 to 5 (1 represents Strong Buy and 5 means Sell). The stock currently has P/E of 17.22 for trailing twelve months while its Forward P/E is 11.77.

Cardinal Health, Inc. (NYSE:CAH) touched its 52-Week High of $91.23 on Dec 29, 2015 while it’s 52-Week Low of $62.7 on Nov 8, 2016. The company currently has Return on Assets of 4 percent, Return on Equity of 20.4% and Return on Investment of 13.3 percent. The stock currently showing Weekly Volatility of 1.67%% and Monthly Volatility of 2.89% Percent with Average True Range of 1.92 and Beta of 0.72.

The 16 analysts offering 12-month price forecasts for Cardinal Health Inc have a median target of 79.50, with a high estimate of 97.00 and a low estimate of 72.00. The median estimate represents a +11.99% increase from the last price of 70.99.

Press Release:

The Company on 3 November declared that the board of directors approved a regular quarterly dividend of $0.4489 per share, payable Jan. 15, 2017, to shareholders of record on Jan. 3, 2017.

In addition, the company today released the preliminary results of shareholder voting at its annual meeting of shareholders. Shareholders elected all 11 members of the board of directors standing for election; ratified Ernst & Young as the company’s independent registered public accounting firm; approved the company’s amended long-term incentive plan; and, approved, on a non-binding advisory basis, the compensation of certain executive officers.

Company Profile:

Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services and Automation and Information Services.